SABA use as an indicator for asthma exacerbation risk: an observational cohort study (SABINA Canada)

BACKGROUND: Patients with asthma use short-acting β-agonists (SABA) to relieve symptoms but SABA alone does not treat underlying inflammation. Thus, over-reliance on SABA may result in poor asthma control and negative health outcomes. OBJECTIVE: To describe use of SABA and characterise the relations...

Descripción completa

Detalles Bibliográficos
Autores principales: Noorduyn, Stephen G., Qian, Christina, Johnston, Karissa M., Soliman, Mena, Talukdar, Manisha, Walker, Brandie L., Hernandez, Paul, Penz, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511146/
https://www.ncbi.nlm.nih.gov/pubmed/36171990
http://dx.doi.org/10.1183/23120541.00140-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511146/
https://www.ncbi.nlm.nih.gov/pubmed/36171990
http://dx.doi.org/10.1183/23120541.00140-2022

Ejemplares similares